Efficacy and safety of tacrolimus versus cyclosporine in kidney and pancreas transplant recipients

被引：11
|
作者：
ElGhoroury, M [1 ]
Hariharan, S [1 ]
Peddi, VR [1 ]
Munda, R [1 ]
Schroeder, TJ [1 ]
Demmy, AM [1 ]
Alexander, JW [1 ]
First, MR [1 ]
机构：
[1] UNIV CINCINNATI, DIV NEPHROL, MED CTR, CINCINNATI, OH 45267 USA
来源：
TRANSPLANTATION PROCEEDINGS | 1997年 / 29卷 / 1-2期
关键词：
D O I：
10.1016/S0041-1345(96)00380-6
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：649 / 651
页数：3
相关论文
共 50 条
  • [31] Safety and Efficacy of Perioperative Sublingual Tacrolimus in Pancreas Transplant Compared With Oral Tacrolimus
    Patel, Neha
    Perez, Caroline
    Taber, David J.
    Kalbavi, Vishal
    Gonzales, Haley
    Rohan, Vinyak
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2021, 19 (06) : 592 - 595
  • [32] Efficacy and Safety of a High Dose Ganciclovir Dosing Strategy in Kidney and Pancreas Transplant Recipients
    Jorgenson, M.
    Descourouez, J.
    Leverson, G.
    Saddler, C.
    Smith, J.
    Mandelbrot, D.
    Odorico, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 631 - 631
  • [33] EFFECT OF CYCLOSPORINE ON THE ENDOCRINE AND EXOCRINE PANCREAS IN KIDNEY-TRANSPLANT RECIPIENTS
    YOSHIMURA, N
    NAKAI, I
    OHMORI, Y
    AIKAWA, I
    FUKUDA, M
    YASUMURA, T
    MATSUI, S
    HAMASHIMA, T
    OKA, T
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1988, 12 (01) : 11 - 17
  • [34] Efficacy and Safety of Combination Therapy With Tacrolimus and Sirolimus in Immunological High Risk Kidney Transplant Recipients
    Lee, J.
    Kim, B.
    Lee, J.
    Lee, J.
    Choi, G.
    Kim, M.
    Kim, Y.
    Park, K.
    Huh, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 454 - 454
  • [35] Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients
    Webster, A.
    Woodroffe, R. C.
    Taylor, R. S.
    Chapman, J. R.
    Craig, J. C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (04):
  • [36] Efficacy and Safety of Combination Therapy With Tacrolimus and Sirolimus in Immunological High Risk Kidney Transplant Recipients
    Lee, J.
    Kim, B.
    Lee, J.
    Lee, J.
    Choi, G.
    Kim, M.
    Kim, Y.
    Park, K.
    Huh, K.
    TRANSPLANTATION, 2014, 98 : 454 - 454
  • [37] CYCLOSPORINE PHARMACOKINETICS IN PANCREAS TRANSPLANT RECIPIENTS
    MUNDA, R
    SCHROEDER, TJ
    PEDERSEN, SA
    CLARDY, CW
    WADHWA, NK
    MYRE, SA
    STEPHENS, GW
    PESCE, AJ
    ALEXANDER, JW
    FIRST, MR
    TRANSPLANTATION PROCEEDINGS, 1988, 20 (02) : 487 - 490
  • [38] Tacrolimus (FK506) versus cyclosporine microemulsion (Neoral) as maintenance immunosuppression therapy in kidney transplant recipients
    Abou-Jaoude, MM
    Najm, R
    Shaheen, J
    Nawfal, N
    Abboud, S
    AlHabash, M
    Darwish, M
    Mulhem, A
    Ojjeh, A
    Almawi, WY
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (07) : 3025 - 3028
  • [39] Long term efficacy of simvastatin in renal transplant recipients treated with cyclosporine or tacrolimus
    Imamura, R
    Ichimaru, N
    Moriyama, T
    Shi, Y
    Namba, Y
    Nonomura, N
    Matsumiya, K
    Toki, K
    Takahara, S
    Okuyama, A
    CLINICAL TRANSPLANTATION, 2005, 19 (05) : 616 - 621
  • [40] Subdinical inflammation in renal transplant recipients: Impact of cyclosporine microemulsion versus tacrolimus
    Lauzurica, R.
    Pastor, M. C.
    Bayes, B.
    Malumbres, S.
    Homs, M.
    Llopis, M. A.
    Bonet, J.
    Romero, R.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (07) : 2170 - 2172
12345